InvestorsHub Logo
Followers 79
Posts 6124
Boards Moderated 0
Alias Born 12/02/2009

Re: hardlesson post# 65857

Wednesday, 10/02/2024 10:47:31 AM

Wednesday, October 02, 2024 10:47:31 AM

Post# of 65997
"Moreover, Dr. Kawamura has authored patents in gene editing technology, including the ABBIE technology. Dr. Kawamura has an extensive peer reviewed publication track record and will also support grant writing initiatives."

https://www.accesswire.com/895708/sohm-inc-announce-dr-tetsuya-kawamura-ph-d-joined-as-a-cell-engineer-and-biochemist

"Dr. Kawamura's diverse academic background and professional experience with genome editing, molecular biology, and biochemistry will be instrumental in our advancement and commercialization of ABBIE gene editing technology. His entry greatly aids our timely release of ABBIE kits as we announced earlier in the current quarter."

___
Add Dr Kawamura, along with Eric Furman, our IP Attorney, Gallegos, Coastar, Stanford Medicine, and Joseph Jackson III, and this gets even more interesting, imo.

Furman: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173289185

Knobbe Martens: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173246026

___
Big green candles have to be coming? imo.